Microbot Medical
MBOT
33 hedge funds and large institutions have $1.77M invested in Microbot Medical in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 8 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
3.2% less ownership
Funds ownership: 13.26% → 10.06% (-3.2%)
8% less funds holding
Funds holding: 36 → 33 (-3)
31% less capital invested
Capital invested by funds: $2.57M → $1.77M (-$798K)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$510K |
| 2 |
DAM
Diamant Asset Management
Ridgefield,
Connecticut
|
+$12.7K |
| 3 |
KWA
Kingswood Wealth Advisors
San Diego,
California
|
+$12.7K |
| 4 |
HH
Hilltop Holdings
Dallas,
Texas
|
+$7.42K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$492K |
| 2 |
HF
HRT Financial
New York
|
-$95K |
| 3 |
Morgan Stanley
New York
|
-$82.3K |
| 4 |
VF
Virtu Financial
New York
|
-$69K |
| 5 |
Renaissance Technologies
New York
|
-$30.8K |
MBOT Hedge Fund Activity: Q1 2024 in Review
33 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2024, worth a combined $1.77M — down 31% from $2.57M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of MBOT and 5 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 8 added.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $510K. The largest seller was Armistice Capital, exiting entirely with an estimated $492K sold.
- 33 institutional investors held Microbot Medical (MBOT) as of Q1 2024, down from 36 in Q4 2023.
- Funds reported $1.77M of Microbot Medical stock for Q1 2024, down 31% quarter-over-quarter.
- 5 funds opened new Microbot Medical positions in Q1 2024 and 8 closed out, a net change of -3 holders.
- The largest Microbot Medical buyer in Q1 2024 was Hudson Bay Capital Management, an estimated $510K added.
- The largest Microbot Medical seller in Q1 2024 was Armistice Capital, an estimated $492K sold.
Based on aggregated 13F filings for Q1 2024.